Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin versus isoniazid for latent tuberculosis infection in liver transplant candidates
2010-022302-41Phase 3Terminated
- Sponsor
- CAIBER
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in latent tuberculosis infection (LTBI) comparing Levofloxacin arm with Isoniazid arm (2 arms). Primary endpoints: Efficacy: development of tuberculosis and Safety: adverse effects with special attention to hepatotoxicity. Started Nov 2010; status: terminated.
02
Drugs
levofloxacinisoniazid
03
Conditions
latent tuberculosis infection (LTBI)
Beyond the preview
Go deeper on 2010-022302-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022302-41.